Compare ETS & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETS | POM |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | China |
| Employees | 26 | 165 |
| Industry | Trucking Freight/Courier Services | Other Specialty Stores |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 11.3M |
| IPO Year | N/A | N/A |
| Metric | ETS | POM |
|---|---|---|
| Price | $0.80 | $1.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 176.3K | ★ 464.3K |
| Earning Date | 04-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.06 |
| 52 Week High | $1.21 | $6.43 |
| Indicator | ETS | POM |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 76.46 |
| Support Level | $0.80 | $0.17 |
| Resistance Level | $0.81 | $5.00 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 57.40 | 96.91 |
Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.